(Sarasota, FL – March 20, 2018) The first Biomet M2a metal on metal hip replacement trial in the United States is set for September 2018 in Ft. Lauderdale, Florida. It is a significant legal challenge to Biomet Orthopedics since the company has not yet faced a single trial over their M2a-38 and M2a-Magnum hips. The injured patients represented by Maglio Christopher & Toale, P.A. suffered from severe pseudotumors as well as tissue and muscle death from their Biomet M2a hip implants. Surgeons for all 3 victims had to remove the defective Biomet M2a hip replacements, surgically cut out the pseudotumors, and dead tissue, and then put in a different type of hip implant. In addition to the Ft. Lauderdale lawsuit, Maglio Christopher & Toale, P.A. has filed complaints and is preparing for multiple trials against Biomet in state courts around the country.